ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
웰니스 유전체학 시장 규모는 향후 몇 년 동안 연평균 13.6%의 성장률로 2029년까지 94억 6,000만 달러에 달할 것으로 예측됩니다. 예측 기간 동안의 성장은 검사 비용의 하락, 헬스케어 투자 확대, 개인 맞춤형 영양에 대한 관심 증가, 가처분 소득 증가, 노인 인구 증가, 개인 맞춤형 건강 및 웰빙에 대한 수요 증가에 기인합니다. 예측 기간 동안 주요 동향으로는 시퀀싱 기술의 발전, 통찰력을 위한 AI 통합, 다유전자 위험 개발, DTC 플랫폼의 발전, 디지털 헬스 통합, 기술 제휴 가속화 등이 있습니다.
맞춤형 의료에 대한 수요 증가는 향후 몇 년 동안 웰니스 유전체학 시장의 성장을 가속할 것으로 예측됩니다. 맞춤형 의료는 보다 정확하고 효과적인 결과를 얻기 위해 개인의 특정 유전자 프로파일, 라이프스타일, 건강 상태에 따라 치료와 관리를 맞춤화하는 헬스케어 접근법입니다. 유전자 기술의 발전으로 개인별 유전자 구성에 따라 보다 정확한 치료 계획을 세우고, 표적화되고 효율적인 치료를 할 수 있게 되면서 그 수요가 증가하고 있습니다. 웰니스 유전체학은 개인의 생물학적 특성에 따라 개인화된 라이프스타일과 예방적 건강 전략을 유도하는 유전학적 통찰력을 제공함으로써 맞춤형 의료에 기여하고 있습니다. 예를 들어, 2024년 2월 미국 비영리단체인 개인맞춤의료연합(Personalized Medicine Coalition)은 2023년 FDA가 희귀질환 환자를 위한 16개의 새로운 개인맞춤형 치료제를 승인했다고 보고했습니다. 그 결과, 맞춤형 의료에 대한 수요 증가는 웰니스 유전체학 시장의 성장을 가속하고 있습니다.
웰니스 유전체학 분야의 주요 기업들은 유전자 데이터를 기반으로 맞춤형 건강 인사이트와 라이프스타일 가이드를 제공하는 개인 맞춤형 유전체학 플랫폼과 같은 혁신적인 솔루션 개발에 집중하고 있습니다. 개인 맞춤형 유전체 플랫폼은 개인의 유전 정보를 해석하여 맞춤형 건강 제안을 제공하는 서비스 및 기술을 말합니다. 예를 들어, 2024년 9월 인도에 본사를 둔 진단 업체인 Neuberg Diagnostics Private Limited는 유전자 분석을 통해 개인 맞춤형 건강 통찰력을 제공하도록 설계된 개인화 유전체학 플랫폼인 Geniee를 발표했습니다. Geniee는 광범위한 유전자 검사를 제공하여 개인이 자신의 유전자가 약물, 영양, 운동, 식사에 대한 반응에 어떻게 영향을 미치는지 이해할 수 있도록 돕습니다. 이 정보를 통해 사용자는 맞춤형 웰빙 전략, 조기 위험 식별, 더 나은 치료 옵션을 통해 건강을 개선할 수 있습니다. 이 플랫폼은 사용자가 자신의 건강을 관리할 수 있도록 설계되었으며, 맞춤형 의료 및 예방 의학의 중요한 진보를 상징합니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 - 금리, 인플레이션, 지정학, 무역 전쟁과 관세, 그리고 코로나재난과 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계 웰니스 유전체학 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 이용 산업 분석
세계의 웰니스 유전체학 시장 : 성장률 분석
세계의 웰니스 유전체학 시장 실적 : 규모와 성장, 2019-2024
세계의 웰니스 유전체학 시장 예측 : 규모와 성장, 2024-2029, 2034F
세계 웰니스 유전체학 전체 시장(TAM)
제6장 시장 세분화
세계의 웰니스 유전체학 시장 : 유형별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
예측 테스트
소비자 유전체학
기타 유형
세계의 웰니스 유전체학 시장 : 설정 유형별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
소비자 직접 판매(DTC)
프로
세계의 웰니스 유전체학 시장 : 용도별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
유방암 및 난소암 검진
당뇨병 스크리닝 및 모니터링
대장암 검진
알츠하이머병
전립선암 검진
정형외과 및 근골격 스크리닝
기타 용도
세계의 웰니스 유전체학 시장 : 예측 테스트 유형별 세분화, 분석과 예측, 2019-2024, 2024-2029F, 2034F
영양 유전체학 검사
피트니스 유전체 검사
질환 감수성 시험
세계의 웰니스 유전체학 시장 : 소비자 유전체학 유형별 세분화, 분석과 예측, 2019-2024, 2024-2029F, 2034F
혈통 및 유산 분석
개인 특성 분석
소비자 직접 의뢰(DTC) 웰니스 키트
세계의 웰니스 유전체학 시장 : 기타 유형별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
에피제네틱 검사
마이크로바이옴 및 장건강 유전체학
라이프스타일 약물을 위한 약물유전체학
제7장 지역별/국가별 분석
세계의 웰니스 유전체학 시장 : 지역별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
세계의 웰니스 유전체학 시장 : 국가별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
웰니스 유전체학 시장 : 경쟁 구도
웰니스 유전체학 시장 : 기업 개요
Danaher Corporation : 개요, 제품 및 서비스, 전략 및 재무 분석
Eurofins Scientific SE : 개요, 제품 및 서비스, 전략 및 재무 분석
BGI Group : 개요, 제품 및 서비스, 전략 및 재무 분석
Agilent Technologies Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
Bio-Rad Laboratories Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
23andMe Holding Co.
Color Health Inc.
Variantyx Inc.
Segterra Inc.
Dante Labs Inc.
Pathway Genomics Corporation
NMC Healthcare LLC
Futura Genetics Ltd.
Genopalate Inc.
OhMyGene Inc.
Rootine Labs Inc.
Tania Flack Naturopath
Toolbox Genomics Inc.
Xcode Life Sciences Pvt. Ltd.
GenepoweRx Healthcare Pvt. Ltd.
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장 잠재력이 높은 국가, 부문, 전략
웰니스 유전체학 시장(2029년) : 새로운 기회를 제공하는 국가
웰니스 유전체학 시장(2029년) : 새로운 기회를 제공하는 부문
웰니스 유전체학 시장(2029년) : 성장 전략
시장 동향에 근거한 전략
경쟁 전략
제36장 부록
LSH
영문 목차
영문목차
Wellness genomics involves utilizing an individual's genetic data to offer tailored guidance for enhancing health, nutrition, fitness, and overall well-being. Its objective is to improve lifestyle decisions and prevent illness by examining genetic tendencies beyond the scope of traditional medical genetics.
The primary types of wellness genomics include predictive testing, consumer genomics, and others. Predictive testing refers to a genetic assessment used to identify whether an individual without symptoms carries a gene variant that could lead to a future illness. This testing is applied in multiple contexts, such as direct-to-consumer (DTC) and professional settings, and serves numerous purposes including screening for breast and ovarian cancer, diabetes monitoring, colon cancer, Alzheimer's disease, prostate cancer, orthopedic and musculoskeletal conditions, among others.
The wellness genomics market research report is one of a series of new reports from The Business Research Company that provides wellness genomics market statistics, including wellness genomics industry global market size, regional shares, competitors with a wellness genomics market share, detailed wellness genomics market segments, market trends and opportunities, and any further data you may need to thrive in the wellness genomics industry. This wellness genomics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The wellness genomics market size has grown rapidly in recent years. It will grow from $4.99 billion in 2024 to $5.68 billion in 2025 at a compound annual growth rate (CAGR) of 13.8%. The growth during the historic period can be credited to the rising prevalence of chronic diseases, heightened consumer awareness about health, increased demand for personalized healthcare, a stronger emphasis on preventive healthcare, and the expansion of direct-to-consumer genomics.
The wellness genomics market size is expected to see rapid growth in the next few years. It will grow to $9.46 billion in 2029 at a compound annual growth rate (CAGR) of 13.6%. The growth in the forecast period can be attributed to increasing affordability of testing, growing healthcare investments, increasing personalized nutrition interest, increasing disposable incomes, a growing geriatric population, and growing demand for personalized health and wellness. Major trends in the forecast period include advancements in sequencing tech, AI integration for insights, polygenic risk developments, DTC platform advancements, digital health integration, and tech partnerships acceleration.
The growing demand for personalized medicine is expected to drive the expansion of the wellness genomics market in the coming years. Personalized medicine is a healthcare approach that customizes treatment and care based on an individual's specific genetic profile, lifestyle, and health conditions to achieve more accurate and effective outcomes. This demand is increasing as advancements in genetic technologies allow for more precise treatment plans tailored to an individual's unique genetic makeup, resulting in targeted and efficient therapies. Wellness genomics contributes to personalized medicine by offering genetic insights that guide personalized lifestyle and preventive health strategies based on individual biology. For example, in February 2024, the Personalized Medicine Coalition, a US-based non-profit, reported that the FDA approved 16 new personalized therapies for rare disease patients in 2023, more than double the six approved in 2022. As a result, the rising demand for personalized medicine is boosting the growth of the wellness genomics market.
Leading companies in the wellness genomics sector are concentrating on the development of innovative solutions, such as personalized genomics platforms, to deliver customized health insights and lifestyle guidance based on genetic data. A personalized genomics platform refers to a service or technology that interprets an individual's genetic information to provide tailored health recommendations. For instance, in September 2024, Neuberg Diagnostics Private Limited, an India-based diagnostics provider, introduced Geniee, a personalized genomics platform designed to generate individualized health insights using genetic analysis. Geniee delivers extensive genetic testing to help individuals understand how their genes affect responses to medications, nutrition, exercise, and diet. This information enables users to improve their health through customized wellness strategies, early risk identification, and better treatment options. The platform is designed to empower users to take charge of their health, representing a significant advancement in personalized medicine and preventive care.
In September 2023, InformedDNA, a US-based precision health firm, acquired gWell Health for an undisclosed sum. The acquisition is intended to merge gWell's personalized wellness technology with InformedDNA's expertise in clinical genetics, broadening the application of precision healthcare in areas such as oncology, drug metabolism, and maternity care. It also aims to make genomic-guided health decisions more widely accessible. gWell Health, a US-based digital wellness company, specializes in applying genomics to develop personalized wellness programs.
Major players in the wellness genomics market are Danaher Corporation, Eurofins Scientific SE, BGI Group, Agilent Technologies Inc., Bio-Rad Laboratories Inc., 23andMe Holding Co., Color Health Inc., Variantyx Inc., Segterra Inc., Dante Labs Inc., Pathway Genomics Corporation, NMC Healthcare LLC, Futura Genetics Ltd., Genopalate Inc., OhMyGene Inc., Rootine Labs Inc., Tania Flack Naturopath, Toolbox Genomics Inc., and Xcode Life Sciences Pvt. Ltd., GenepoweRx Healthcare Pvt. Ltd., Gx Sciences Inc., and Nebula Genomics Inc.
North America was the largest region in the wellness genomics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in wellness genomics report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the wellness genomics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The wellness genomics market consists of revenues earned by entities providing services such as genetic testing, personalized nutrition analysis, fitness and wellness recommendations, disease risk assessment, ancestry and trait analysis, and preventive healthcare insights. The market value includes the value of related goods sold by the service provider or included within the service offering. The wellness genomics market also includes sales of genetic testing kits, bioinformatics software, personalized health reports, and nutrigenomics supplements. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Wellness Genomics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on wellness genomics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for wellness genomics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The wellness genomics market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Type: Predictive Testing; Consumer Genomics; Other Types
2) By Setting Type: Direct-To Consumer (DTC); Professional
3) By Application: Breast And Ovarian Cancer Screening; Diabetic Screening And Monitoring; Colon Cancer Screening; Alzheimer's Disease; Prostate Cancer Screening; Orthopedic And Musculoskeletal Screening; Other Applications
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Wellness Genomics Market Characteristics
3. Wellness Genomics Market Trends And Strategies
4. Wellness Genomics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
5. Global Wellness Genomics Growth Analysis And Strategic Analysis Framework
5.1. Global Wellness Genomics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Wellness Genomics Market Growth Rate Analysis
5.4. Global Wellness Genomics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Wellness Genomics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Wellness Genomics Total Addressable Market (TAM)
6. Wellness Genomics Market Segmentation
6.1. Global Wellness Genomics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Predictive Testing
Consumer Genomics
Other Types
6.2. Global Wellness Genomics Market, Segmentation By Setting Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Direct-To Consumer (DTC)
Professional
6.3. Global Wellness Genomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Breast And Ovarian Cancer Screening
Diabetic Screening And Monitoring
Colon Cancer Screening
Alzheimer's Disease
Prostate Cancer Screening
Orthopedic And Musculoskeletal Screening
Other Applications
6.4. Global Wellness Genomics Market, Sub-Segmentation Of Predictive Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Nutrigenomics Testing
Fitness Genomics Testing
Disease Susceptibility Testing
6.5. Global Wellness Genomics Market, Sub-Segmentation Of Consumer Genomics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Ancestry And Heritage Analysis
Personal Trait Analysis
Direct-To-Consumer (DTC) Wellness Kits
6.6. Global Wellness Genomics Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Epigenetic Testing
Microbiome And Gut Health Genomics
Pharmacogenomics For Lifestyle Drugs
7. Wellness Genomics Market Regional And Country Analysis
7.1. Global Wellness Genomics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Wellness Genomics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
